Are you referring to page 28of the recent SEC doc? Some of the “contracts” referenced in the filing were already announced in a press release, and others may be forthcoming.
The Company completed negotiations and entered into a contract with a company that has a complementary immunotherapy agent, and the two companies have been engaged for a number of months in joint development of trial designs and selection of candidate cancers for a combination treatment clinical trial
who am I to believe.... very difficult mmm. NWBO's last 10Q or an anonymous poster on Ihub named theorysuit